National HealthCare (NHC)
(Delayed Data from AMEX)
$91.28 USD
+0.51 (0.56%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $91.27 -0.01 (-0.01%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NHC 91.28 +0.51(0.56%)
Will NHC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for NHC based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NHC
Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting
Jefferies Reaffirms Their Hold Rating on New Hope Corporation Limited (NHPEF)
JPMorgan Adjusts Stance on New Hope Corp
Ex-Dividend Reminder: National Healthcare, Danaher and DENTSPLY SIRONA
Analyst Issues Sell Rating for New Hope Corporation Limited Citing Valuation Concerns and Market Trends